Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Multicenter Study to Compare Starting Nevirapine at the Full Dose With Dose Escalation in Patients Who Require Efavirenz to be Withdrawn Due to Adverse Reactions

NCT00704249 is registered in ClinicalTrials.gov with Clinical Trial Agency of HIV Study Group as lead sponsor.

NCT NCT00704249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00704249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Multicenter Study to Compare Starting Nevirapine at the Full Dose With Dose Escalation in Patients Who Require Efavirenz to be Withdrawn Due to Adverse Reactions
Lead sponsor
Clinical Trial Agency of HIV Study Group
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2006
Completion date
February 28, 2009
Enrollment
80 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections